Clinical Trial Update: Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the effects of TC-6499 on gastric emptying time in diabetic subjects with gastroparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• TC-6499

Snippet

Sponsor: Targacept Inc. | Conditions: Gastroparesis | Phase 1, Phase 2 | Status: COMPLETED